All In Biotech

Drug Trial Radar · NCT00310505

Amphotericin B Treatment in Visceral Leishmaniasis

Randomised Double Blind Dose Ranging Study of Amphotericin B in Visceral Leishmaniasis

Last checked: Nov 19, 2026Latest source record: Sep 12, 2008 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 1,500 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,500

Actual

Start

Jan 2003

Primary completion

Not stated

Sponsor

Lead sponsor
Banaras Hindu UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Apr 4, 2006

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 2 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is being conducted to assess the safety and efficacy of amphotericin B deoxycholate in doses of 0.75 mg/kg or 1.0 mg/kg for 15 doses. In each arm the drug is given in the conventional way every alternate day against the daily administration regimen being tested.

Conditions

  • Visceral Leishmaniasis

Interventions

  • Amphotericin B deoxycholate given as daily administrationDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Final cure rate at six months after the end of treatment

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Kala-azar Medical Research Center

    Muzaffarpur, Bihar, India

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.